loader2
NRI

Dec 23, 2024


Category

Equity

AUM (Cr.)

854.32

Exit Load (%)

0.00

Min Inv Lumpsum

1,000

Expense Ratio

2.29

Sharpe Ratio

19.26

Beta Ratio

0.00

Fund Manager

Dhaval Shah

Inception Date

Jul 11, 2019

Risk Level

Very High

Investment Objective

The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes` objectives will be achieved.

Invest Now

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Aditya Birla SL Pharma & Healthcare Fund (IDCW) 2 15.17 35.16 18.83 24.76 23.44
Benchmark - S&P BSE Healthcare TRI -1.88 10.85 37 11.94 22.91 0
Category Average - BEST EQUITY PERFORMERS 1.6 3.23 24.39 18.61 21.56 16.29
Category Rank 5/8 6/8 6/8 7/8 7/8 8/8
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
Nippon India Taiwan Equity Fund (IDCW) 11.8695 1.28 27.41 5.39 0.00 358.08 2.43 500.00 invest
Nippon India Taiwan Equity Fund (G) 11.8695 1.28 27.41 5.39 0.00 358.08 2.43 500.00 invest
Franklin Asian Equity Fund (G) 28.7020 1.11 18.11 -0.59 3.25 245.50 0.00 5,000.00 invest
Franklin Asian Equity Fund (IDCW) 13.5479 1.11 18.11 -0.59 3.25 245.50 0.00 5,000.00 invest
Franklin Build India Fund (IDCW) 43.4184 -7.94 30.36 29.64 27.45 2,848.49 0.00 5,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)
4 Months Trends
Equity-Sun Pharma.Inds. Nov 30, 2024 122.22 14.31 -3.68
Equity-Cipla Nov 30, 2024 77.02 9.02 -1.15
Equity-Torrent Pharma. Nov 30, 2024 71.37 8.35 14.46
Equity-Apollo Hospitals Nov 30, 2024 50.49 5.91 -2.76
Equity-Fortis Health. Nov 30, 2024 47.96 5.61 5.52
Equity-Aurobindo Pharma Nov 30, 2024 43.09 5.04 -9.59
Equity-Lupin Nov 30, 2024 40.24 4.71 12.05
Equity-Ajanta Pharma Nov 30, 2024 39.09 4.58 -1.38
Equity-Ipca Labs. Nov 30, 2024 33.97 3.98 -2.91
Equity-Alkem Lab Nov 30, 2024 28.08 3.29 -2.37

latest news

Aditya Birla Sun Life MF announces Income Distribution cum Capital Withdrawal (IDCW) under its schemes

Aditya Birla Sun Life Mutual Fund has announced 20 December 2024 as the rec...

Dec 18, 2024 09:32

Aditya Birla MF announces change in Fund Manager of the following schemes

Aditya Birla Sun Life Mutual Fund has announced change in Fund Managers of ...

Nov 25, 2024 10:44

Aditya Birla MF announces Income Distribution cum capital withdrawal (IDCW) under its schemes

Aditya Birla Sun Life Mutual Fund has announced 22 November 2024 as the rec...

Nov 19, 2024 10:47

Aditya Birla MF announces Income Distribution cum capital withdrawal (IDCW) under its schemes

Aditya Birla Sun Life Mutual Fund has announced 25 October 2024 as the reco...

Oct 23, 2024 16:39

Aditya Birla Sun Life MF announces change in Fund Manager of the following schemes

Aditya Birla Sun Life Mutual Fund has announced change in Fund Managers of ...

Oct 03, 2024 11:47

Aditya Birla Sun Life Mutual Fund announces change in Key Personnel

Aditya Birla Sun Life Mutual Fund has announced that Mr. Pradeep Sharma has...

Aug 31, 2024 14:32

SCHEME DETAILS

AMC Name : Aditya Birla Sun Life Mutual Fund
Fund Name : Aditya Birla SL Pharma & Healthcare Fund (IDCW)
Contact Persone : Dhaval Shah
Registered Address : One World Centre,Tower 1,17th Flr,Jupiter Mills,senapati BapatMarg,Elphinstone Road, Mumbai 400013
Telephone No : 022 43568000 / 022 43568008
Fax No. : 022 43568110/8111
Email : abslamc.cs:adityabirlacapital.com
Website : https://mutualfund.adityabirlacapital.com